IRVINE, Calif., Feb. 3 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced Vicente Anido, Jr., Ph.D., President and Chief Executive Officer, will present an update on the Company's commercial and clinical progress at the 11th Annual BIO CEO & Investor Conference at 11:00 a.m. Eastern Time on Tuesday, February 10, 2009, in New York.
To access the live audio broadcast or the subsequent archived recording, log onto http://www.istavision.com. Please connect to the website several minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary.
About ISTA Pharmaceuticals
ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.
|SOURCE ISTA Pharmaceuticals, Inc.|
Copyright©2009 PR Newswire.
All rights reserved